New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA Warns Against Eye Drop Linked to Blindness and a Death

The specific strain linked to the outbreak is so rare that the agency has never before seen it in the U.S.

Getty Images

According to a recent Reuter’s article, the FDA has warned against the use of an India-made eye drop linked to a drug-resistant bacteria. The eye drops in question are Artificial Tears manufactured by Global Pharma Healthcare Pvt Ltd. Apparently the company has violated current good manufacturing practices, resulting in 55 adverse events reported in the United States including infections, blindness, and one death with bloodstream infection. Global Pharma Healthcare issued a voluntary recall for unexpired lots of the eye drops that were distributed by EzriCare and Delsam Pharma. 

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts